S100B and early-onset autosomal dominant Alzheimer disease: In the central nervous system (CNS), S100B promotes proliferation and inhibits differentiation of astrocytes [9], and increases in S100B are associated with neural diseases such as amyotrophic lateral sclerosis, multiple sclerosis, depression, Alzheimer's disease, and schizophrenia [10]–[13].